Joyce A. Goldstein

Influence of CYP2C9 and VKORC1 on warfarin response during initiation of therapy.

N. Limdi, T. Beasley, J. Goldstein, 2009, Blood cells, molecules & diseases.

VKORC1 polymorphisms, haplotypes and haplotype groups on warfarin dose among African-Americans and European-Americans.

Nianjun Liu, T Mark Beasley, Donna K Arnett, 2008, Pharmacogenomics.

Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans.

N. Limdi, T. Beasley, G. Mcgwin, 2008, Pharmacogenomics.